Cost-effectiveness of pazopanib: an example of improved transparency and accessibility of industry-sponsored economic evaluations through publication in peer-reviewed journals
Curr Oncol. 2016 Aug;23(4):e327-9.
doi: 10.3747/co.22.2741.
Epub 2016 Aug 12.
1 Pharmacoeconomics Research Unit, Cancer Care Ontario, and Canadian Centre for Applied Research in Cancer Control, Toronto, ON.
2 Sunnybrook Odette Cancer Centre, Canadian Centre for Applied Research in Cancer Control, and Department of Medicine, University of Toronto, Toronto, ON.